Who are Keto Acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): L-alanyl-L-glutamine dipeptide.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/keto-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Keto Acid — Competitive Intelligence Brief

Keto Acid (Keto Acid) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement / Nutritional agent. Area: Nephrology / Hepatology / Nutrition support.

marketed Amino acid supplement / Nutritional agent Nephrology / Hepatology / Nutrition support Small molecule Live · refreshed every 30 min

Target snapshot

Keto Acid (Keto Acid) — Peking University First Hospital. Keto acid provides essential amino acids and nitrogen-sparing substrates to support protein synthesis and reduce protein catabolism in patients with renal or hepatic disease.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Keto Acid TARGET	Keto Acid	Peking University First Hospital	marketed	Amino acid supplement / Nutritional agent
L-alanyl-L-glutamine dipeptide	L-alanyl-L-glutamine dipeptide	National Cardiovascular Center Harapan Kita Hospital Indonesia	phase 3	Amino acid supplement / Nutritional agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement / Nutritional agent class)

National Cardiovascular Center Harapan Kita Hospital Indonesia · 1 drug in this class
Peking University First Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Keto Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/keto-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab